We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+17.29%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.22B
AUM Growth
-$65.3M
Cap. Flow
-$208M
Cap. Flow %
-16.99%
Top 10 Hldgs %
34.8%
Holding
287
New
134
Increased
23
Reduced
46
Closed
28

Top Buys

Rank Stock Value
1
BWA icon
BorgWarner
BWA
+$20.6M
2
HGV icon
Hilton Grand Vacations
HGV
+$19M
3
CVNA icon
Carvana
CVNA
+$12.5M
4
NATL icon
NCR Atleos
NATL
+$9.39M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$6.39M

Top Sells

Rank Stock Value
1
ENVA icon
Enova International
ENVA
+$28.6M
2
FLG
Flagstar Bank National Association
FLG
+$24.5M
3
VST icon
Vistra
VST
+$18.3M
4
NE icon
Noble Corp
NE
+$16.1M
5
PHIN icon
Phinia Inc
PHIN
+$8.72M

Sector Composition

Rank Sector Weight
1 Healthcare 23.14%
2 Consumer Discretionary 18.74%
3 Financials 10.52%
4 Materials 4.8%
5 Industrials 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRML
101
DELISTED
Tourmaline Bio
TRML
$350K 0.03%
+13,356
New +$267K
OMGA
102
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$346K 0.03%
115,000
-393,242
-77% -$797K
ILPT
103
Industrial Logistics Properties Trust
ILPT
$575M
$342K 0.03%
+72,798
New +$236K
APLT
104
DELISTED
Applied Therapeutics
APLT
$338K 0.03%
+100,806
New +$251K
SERA icon
105
Sera Prognostics
SERA
$77.5M
$336K 0.03%
+56,169
New +$163K
ABSI icon
106
Absci
ABSI
$1.42B
$335K 0.03%
+79,780
New +$148K
MTA
107
Metalla Royalty & Streaming
MTA
$780M
$333K 0.03%
+109,080
New +$325K
MAMA icon
108
Mama's Creations
MAMA
$878M
$329K 0.03%
+67,081
New +$265K
AAOI icon
109
Applied Optoelectronics
AAOI
$10.7B
$317K 0.03%
+16,407
New +$214K
FULC icon
110
Fulcrum Therapeutics
FULC
$288M
$316K 0.03%
+46,778
New +$208K
OUST icon
111
Ouster
OUST
$3.1B
$315K 0.03%
+41,121
New +$216K
CCCC icon
112
C4 Therapeutics
CCCC
$398M
$314K 0.03%
+55,602
New +$127K
ABOS icon
113
Acumen Pharmaceuticals
ABOS
$164M
$301K 0.02%
+78,431
New +$233K
BVS icon
114
Bioventus
BVS
$1.03B
$297K 0.02%
+56,389
New +$223K
STTK icon
115
Shattuck Labs
STTK
$715M
$297K 0.02%
+41,638
New +$114K
VTYX
116
DELISTED
Ventyx Biosciences
VTYX
$296K 0.02%
+120,000
New +$1.14M
VIRC icon
117
Virco
VIRC
$95.6M
$296K 0.02%
+24,599
New +$189K
LNKB
118
DELISTED
LINKBANCORP
LNKB
$296K 0.02%
+37,079
New +$245K
LUXH
119
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
$293K 0.02%
+700
New +$228K
IMNM icon
120
Immunome
IMNM
$2.84B
$290K 0.02%
+27,149
New +$226K
USAP
121
DELISTED
Universal Stainless & Alloy
USAP
$288K 0.02%
+14,350
New +$217K
INBK icon
122
First Internet Bancorp
INBK
$254M
$286K 0.02%
+11,813
New +$228K
FINW icon
123
FinWise Bancorp
FINW
$191M
$285K 0.02%
+19,913
New +$212K
SYRS
124
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$284K 0.02%
+36,444
New +$125K
RDNW
125
RideNow Group
RDNW
$259M
$284K 0.02%
+34,843
New +$223K
3 4
5
6 7

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, 683 Capital Management held 287 positions worth $1.22B, down 5.1% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

683 Capital Management withdrew a net $208M in Q4 2023, closing 28 positions and reducing 46 holdings. Its most notable exit was Hess, an estimated $7.65M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in NCR Atleos worth $9.96M.

  • 683 Capital Management's largest Q4 2023 buy was NCR Atleos: 410,000 shares worth $9.96M.
  • 683 Capital Management added most to BorgWarner in Q4 2023, an estimated $20.6M increase.
  • 683 Capital Management's biggest Q4 2023 reduction was Enova International, cutting an estimated $28.6M.
  • 683 Capital Management fully exited Hess in Q4 2023, selling an estimated $7.65M.
  • 683 Capital Management's ten largest holdings make up 35% of its $1.22B portfolio in Q4 2023.
  • 683 Capital Management opened 134 new positions and closed 28 in Q4 2023.
  • 683 Capital Management's portfolio value fell 5.1% quarter-over-quarter to $1.22B.

Based on 683 Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.